A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Item 1. Business. Analysis at the Speed of Life We are making revolutionizing chemical and biochemical analysis simple, smart and speedy with our purpose-built handheld and desktop devices that empower people to take swift action in life-altering applications. Company Overview We have developed an innovative suite of purpose-built handheld and desktop devices for point-of-need chemical analysis. Leveraging mass spectrometry, or Mass Spec, and optical spectroscopy, microfluidics, and analytics and machine learning technologies, we make devices that are significantly smaller and more accessible than conventional laboratory instruments. Our devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 58M | 60M | 50M | 47M | 42M | 27M |
| Net Income | -4.1M | -72M | -36M | -34M | -22M | -13M |
| EPS | $-0.13 | $-2.12 | $-1.13 | $-1.07 | $-0.79 | $-2.35 |
| Free Cash Flow | -28M | -31M | -27M | -23M | -30M | 4.1M |
| ROIC | -204.5% | -63.0% | -22.0% | -16.3% | -9.7% | -8.4% |
| Gross Margin | 49.2% | 50.1% | 50.4% | 55.5% | 55.0% | 55.5% |
| Debt/Equity | 0.00 | 0.39 | 0.23 | 0.08 | 0.07 | 0.11 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -63M | -77M | -43M | -35M | -22M | -5.8M |
| Operating Margin | -108.9% | -128.7% | -85.1% | -75.5% | -52.3% | -21.6% |
| ROE | -3.0% | -51.6% | -22.0% | -17.6% | -10.3% | -9.3% |
| Shares Outstanding | 36M | 34M | 32M | 31M | 28M | 31M |
| Metric | 2020 | 2021 | 2022 | |||
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 27M | 42M | 47M | 50M | 60M | 58M |
| Gross Margin | 55.5% | 55.0% | 55.5% | 50.4% | 50.1% | 49.2% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -5.8M | -22M | -35M | -43M | -77M | -63M |
| Op. Margin | -21.6% | -52.3% | -75.5% | -85.1% | -128.7% | -108.9% |
| Net Income | -13M | -22M | -34M | -36M | -72M | -4.1M |
| Net Margin | -48.0% | -52.5% | -71.6% | -72.5% | -121.1% | -7.2% |
| Non-Recurring | 0 | 0 | 0 | 0 | 41M | 41M |
| Returns on Capital | ||||||
| ROIC | -8.4% | -9.7% | -16.3% | -22.0% | -63.0% | N/M |
| ROE | -9.3% | -10.3% | -17.6% | -22.0% | -51.6% | -3.0% |
| ROA | -7.2% | -8.5% | -13.8% | -17.9% | -39.8% | -2.2% |
| Cash Flow | ||||||
| Op. Cash Flow | 4.1M | -29M | -21M | -25M | -30M | -27M |
| Free Cash Flow | 4.1M | -30M | -23M | -27M | -31M | -28M |
| Owner Earnings | 2.8M | -33M | -30M | -37M | -47M | -44M |
| CapEx | 9K | 737K | 2.0M | 2.0M | 602K | 1.2M |
| Maint. CapEx | 831K | 925K | 1.6M | 2.4M | 4.7M | 4.7M |
| Growth CapEx | 0 | 0 | 431K | 0 | 0 | 0 |
| D&A | 831K | 925K | 1.6M | 2.4M | 4.7M | 4.7M |
| CapEx/OCF | 0.2% | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 525K | 2.5M | 7.2M | 9.8M | 12M | 12M |
| Debt Repayment | 0 | 39K | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | -144M | -209M | -173M | N/A | N/A | -112M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A | 112M |
| Long-Term Debt | 14M | 15M | 15M | N/A | N/A | N/A |
| Debt/Equity | 0.11 | 0.07 | 0.08 | 0.23 | 0.39 | 0.00 |
| Interest Coverage | -6.0 | -45.4 | -274.3 | -212.7 | N/A | N/A |
| Equity | 139M | 215M | 191M | 165M | 115M | 136M |
| Total Assets | 179M | 261M | 243M | 203M | 159M | 191M |
| Total Liabilities | 40M | 46M | 52M | 37M | 45M | 55M |
| Intangibles | N/A | N/A | 19M | 18M | 45M | 45M |
| Retained Earnings | -78M | -101M | -134M | -171M | -243M | -243M |
| Working Capital | 160M | 238M | 196M | 151M | 78M | 78M |
| Current Assets | 171M | 253M | 216M | 174M | 103M | 103M |
| Current Liabilities | 11M | 15M | 19M | 23M | 25M | 25M |
| Per Share Data | ||||||
| EPS | -2.35 | -0.79 | -1.07 | -1.13 | -2.12 | -0.13 |
| Owner EPS | 0.09 | -1.16 | -0.95 | -1.16 | -1.37 | -1.21 |
| Book Value | 4.45 | 7.65 | 6.08 | 5.14 | 3.36 | 3.77 |
| Cash Flow/Share | 0.13 | -1.04 | -0.67 | -0.78 | -0.89 | 0.02 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 31.2M | 28.1M | 31.4M | 32.2M | 34.1M | 36.2M |
| Valuation | ||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -55.4 |
| P/FCF | 506.6 | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 15.0 | 3.2 | 1.2 | 2.4 | 0.7 | 1.9 |
| Price/Sales | 68.2 | 27.8 | 11.1 | 4.9 | 3.0 | 4.5 |
| FCF Yield | 0.2% | -4.3% | -10.5% | -6.8% | -40.1% | -10.9% |
| Market Cap | 2.1B | 695M | 220M | 400M | 77M | 261M |
| Avg. Price | 58.73 | 41.74 | 16.59 | 7.66 | 5.21 | 7.20 |
| Year-End Price | 66.86 | 24.78 | 7.00 | 12.41 | 2.26 | 7.20 |
908 Devices Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 53.3%.
908 Devices Inc. (MASS) has a 5-year average return on invested capital (ROIC) of -23.9%. This is below average and may indicate limited pricing power.
908 Devices Inc. (MASS) has a market capitalization of $261M. It is classified as a small-cap stock.
908 Devices Inc. (MASS) does not currently pay a regular dividend.
908 Devices Inc. (MASS) operates in the Measuring & Controlling Devices, Nec industry, within the Technology sector.
908 Devices Inc. (MASS) reported annual revenue of $60 million in its most recent fiscal year, based on SEC EDGAR filings.
908 Devices Inc. (MASS) has a net profit margin of -121.1%. The company is currently unprofitable.
908 Devices Inc. (MASS) generated $-31 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
908 Devices Inc. (MASS) has a debt-to-equity ratio of 0.39. This indicates a conservatively financed balance sheet.
908 Devices Inc. (MASS) reported earnings per share (EPS) of $-2.12 in its most recent fiscal year.
908 Devices Inc. (MASS) has a return on equity (ROE) of -51.6%. A negative ROE may indicate losses or negative equity.
908 Devices Inc. (MASS) has a 5-year average gross margin of 53.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 5 years of financial data for 908 Devices Inc. (MASS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
908 Devices Inc. (MASS) has a book value per share of $3.36, based on its most recent annual SEC filing.
No recent press releases.